Term
| Diphenoxylate/atropine- Lomotil (CV); Loperamide- Imodium |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Bismuth subsalicylate- PeptoBismol |
|
Definition
|
|
Term
|
Definition
|
|
Term
| delays transit time, increases contact time and absorption, |
|
Definition
| Loperamide (Imodium), diphenoxylate/atropine (Lomotil) |
|
|
Term
| inhibits chloride-rich secretion |
|
Definition
|
|
Term
| Used for traveler's diarrhea, non-specific acute diarrhea, or chronic diarrhea associated with IBD; may be used when patient is afebrile or has low grade fever and does not have blood stools; Use caution in bacterial diarrhea when endotoxins are causative agents |
|
Definition
|
|
Term
| Commonly used agent: Fiber |
|
Definition
|
|
Term
| ADRs: constipation, dizziness, dry eyes/mouth, fatigue, abdominal pain; Not to be used in bacterial/parasitic infections*** |
|
Definition
|
|
Term
| MOA: non-selective adsorption of bacteria, toxins, various noxious materials, nutrients, digestive enzymes, and drugs |
|
Definition
|
|
Term
|
Definition
| also a bulk-forming laxative |
|
|
Term
| absorbs water, forms bulk gel; promotes normal motility and peristalsis; 12-72 hours to act |
|
Definition
|
|
Term
| Decreases mucosal secretions; low absorption, limited to gut; some anti-infective qualities; recommended for traveler's diarrhea |
|
Definition
| Bismuth subsalicylate (Pepto Bismol, Kaopectate) |
|
|
Term
| Symptomatic relief of mild, non-specific diarrhea; indigestion; treatment and prevention of travelers diarrhea; adjuvant treatment of H. pylori-associated peptic ulcer disease |
|
Definition
|
|
Term
| Patients should not take BSS with this to avoid toxicity |
|
Definition
|
|
Term
| Bismuth subsalicylate interactions |
|
Definition
| warfarin, methotrexate, probenecid |
|
|
